Brandinium

Trademark search for:

AKTISENSE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2009-06-09 — Application filed
  • 2009-10-01 — Sn assigned for sect 66a appl from ib
  • 2009-10-09 — Application filed
  • 2009-10-09 — Assigned to examiner
  • 2009-10-13 — Application filed
  • 2009-10-15 — Final disposition recorded
  • 2009-10-16 — Office action issued
  • 2009-10-16 — Office action issued
  • 2009-10-16 — Office action issued
  • 2009-11-06 — Office action issued
  • 2010-04-16 — Teas change of correspondence received
  • 2010-04-16 — Teas/email correspondence entered
  • 2010-04-16 — Office action issued
  • 2010-04-16 — Correspondence received in law office
  • 2010-04-19 — Approved for pub - principal register
  • 2010-04-29 — Assigned to lie
  • 2010-04-29 — Law office publication review completed
  • 2010-06-01 — Published for opposition
  • 2010-06-01 — Official gazette publication confirmation e-mailed
  • 2010-08-17 — Registered-principal register
  • 2010-11-17 — Final disposition recorded
  • 2010-11-18 — Final disposition recorded
  • 2010-11-18 — Final disposition recorded
  • 2013-02-13 — Final disposition recorded
  • 2016-08-11 — New representative at ib received
  • 2017-04-07 — Cancelled section 71
  • 2017-12-07 — Total invalidation of reg ext protection created
  • 2017-12-16 — Total invalidation of reg ext protection sent to ib
  • 2017-12-16 — Invalidation processed
  • 2018-01-16 — Total invalidation processed by the ib
  • 2019-06-09 — Final status recorded
  • 2020-01-03 — Death of international registration
  • 2020-01-03 — Notification of effect of cancellation of intl reg mailed

Owner Information

ANTISENSE Pharma GmbH
DE
ANTISENSE Pharma GmbH
DE
ANTISENSE Pharma GmbH
DE

Correspondent

Lawrence E. Abelman Abelman Frayne & Schwab
666 Third Avenue
10th Floor
New York, NY 10017

Filing Details

Filing Date:
2009-06-09
Status Date:
2019-06-09
Category:
Pharmaceuticals
Filing Year:
2009

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.